International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyAnna Nowak‐Węgrzyn, Matthew Greenhawt, R.J.K. Wood et al.|Journal of Allergy and Clinical Immunology|2017Cited by 675
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Jonathan M. Spergel et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Wayne G. Shreffler et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101